BR112013018453A2 - métodos e composições para a prevenção e tratamento de osteoartrite - Google Patents
métodos e composições para a prevenção e tratamento de osteoartriteInfo
- Publication number
- BR112013018453A2 BR112013018453A2 BR112013018453A BR112013018453A BR112013018453A2 BR 112013018453 A2 BR112013018453 A2 BR 112013018453A2 BR 112013018453 A BR112013018453 A BR 112013018453A BR 112013018453 A BR112013018453 A BR 112013018453A BR 112013018453 A2 BR112013018453 A2 BR 112013018453A2
- Authority
- BR
- Brazil
- Prior art keywords
- osteoarthritis
- prevention
- compositions
- treatment
- methods
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 201000008482 osteoarthritis Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201061459902P | 2010-12-21 | 2010-12-21 | |
PCT/US2011/065173 WO2012087745A1 (en) | 2010-12-21 | 2011-12-15 | Methods and compositions for preventing and treating osteoarthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013018453A2 true BR112013018453A2 (pt) | 2018-05-22 |
Family
ID=46314373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013018453A BR112013018453A2 (pt) | 2010-12-21 | 2011-12-15 | métodos e composições para a prevenção e tratamento de osteoartrite |
Country Status (11)
Country | Link |
---|---|
US (1) | US20140205569A1 (pt) |
EP (1) | EP2654744A4 (pt) |
JP (1) | JP2014505679A (pt) |
CN (1) | CN103384521A (pt) |
AU (1) | AU2011349718B2 (pt) |
BR (1) | BR112013018453A2 (pt) |
CA (1) | CA2822263A1 (pt) |
MX (1) | MX2013007191A (pt) |
RU (1) | RU2013133998A (pt) |
WO (1) | WO2012087745A1 (pt) |
ZA (1) | ZA201305497B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
WO2014022816A2 (en) * | 2012-08-03 | 2014-02-06 | Dignity Sciences Limited | Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same |
KR102391827B1 (ko) | 2014-06-04 | 2022-04-27 | 디에스 바이오파마 리미티드 | Dgla를 포함하는 약제학적 조성물 및 그의 용도 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE49783B1 (en) * | 1979-05-18 | 1985-12-11 | Efamol Ltd | Pharmaceutical and dietary composition comprising epsilon-linolenic acids |
GB9403857D0 (en) * | 1994-03-01 | 1994-04-20 | Scotia Holdings Plc | Fatty acid derivatives |
GB9403855D0 (en) * | 1994-03-01 | 1994-04-20 | Scotia Holdings Plc | Fatty acid derivatives |
DK0790056T3 (da) * | 1995-08-07 | 2005-03-21 | Suntory Ltd | Anvendelse af præparat til forebyggelse eller behandling af sygdomme forårsaget af abnormiteter i bruskvæv |
GB9622636D0 (en) * | 1996-10-30 | 1997-01-08 | Scotia Holdings Plc | Presentation of bioactives |
GB9710351D0 (en) * | 1997-05-20 | 1997-07-16 | Scotia Holdings Plc | Glucosamine fatty acids |
JP4343477B2 (ja) * | 2000-05-25 | 2009-10-14 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | ペットフード用新規プロバイオチックス |
US20020188024A1 (en) * | 2000-08-23 | 2002-12-12 | Chilton Floyd H. | Fatty acid-containing emulsion with increased bioavailability |
US8633247B2 (en) * | 2003-08-11 | 2014-01-21 | Hill's Pet Nutrition, Inc. | Method for decreasing cartilage damage in dogs |
CA2529749C (en) * | 2003-08-11 | 2012-03-20 | Hill's Pet Nutrition, Inc. | Omega-3 fatty acids for the treatment of canine osteoarthritis |
WO2005053710A2 (en) * | 2003-11-21 | 2005-06-16 | Nestec S.A. | Food composition comprising glucosamine |
AU2005259386B2 (en) * | 2004-07-01 | 2011-11-03 | Société des Produits Nestlé S.A. | Canine osteoarthritis diet formulation |
WO2006085687A1 (ja) * | 2005-02-14 | 2006-08-17 | Suntory Limited | ジホモ−γ−リノレン酸(DGLA)を有効成分として含んで成る組成物 |
CA2648273A1 (en) * | 2006-04-03 | 2007-10-11 | Nestec S.A. | Nutritional compositions for promotion of bone growth and maintenance of bone health and methods regarding same |
-
2011
- 2011-12-15 CA CA2822263A patent/CA2822263A1/en not_active Abandoned
- 2011-12-15 WO PCT/US2011/065173 patent/WO2012087745A1/en active Application Filing
- 2011-12-15 JP JP2013546228A patent/JP2014505679A/ja active Pending
- 2011-12-15 MX MX2013007191A patent/MX2013007191A/es unknown
- 2011-12-15 BR BR112013018453A patent/BR112013018453A2/pt not_active IP Right Cessation
- 2011-12-15 RU RU2013133998/15A patent/RU2013133998A/ru not_active Application Discontinuation
- 2011-12-15 EP EP11850141.0A patent/EP2654744A4/en not_active Withdrawn
- 2011-12-15 AU AU2011349718A patent/AU2011349718B2/en not_active Ceased
- 2011-12-15 CN CN2011800680315A patent/CN103384521A/zh active Pending
- 2011-12-15 US US13/996,225 patent/US20140205569A1/en not_active Abandoned
-
2013
- 2013-07-19 ZA ZA2013/05497A patent/ZA201305497B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2011349718B2 (en) | 2017-02-09 |
JP2014505679A (ja) | 2014-03-06 |
EP2654744A4 (en) | 2014-07-02 |
WO2012087745A1 (en) | 2012-06-28 |
MX2013007191A (es) | 2013-07-12 |
US20140205569A1 (en) | 2014-07-24 |
ZA201305497B (en) | 2015-01-28 |
RU2013133998A (ru) | 2015-01-27 |
CA2822263A1 (en) | 2012-06-28 |
EP2654744A1 (en) | 2013-10-30 |
CN103384521A (zh) | 2013-11-06 |
AU2011349718A1 (en) | 2013-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013018754A2 (pt) | combinação de componentes para a prevenção e tratamento de fragilidade | |
BR112013033534A2 (pt) | métodos e composições para inibição de reabsorção de osso | |
BR112012004979A2 (pt) | composições para o tratamento de semente e métodos | |
HK1202071A1 (en) | Biocidal compositions and methods of using the same | |
BR112013019732A2 (pt) | composições e métodos para tratamento de doenças cardiovasculares | |
ZA201304280B (en) | Treatment of jak2-mediated conditions | |
BR112013014943A2 (pt) | compostos úteis para o tratamento de aids | |
BR112013016535A2 (pt) | extratos vegetais para o tratamento e prevenção de infecções | |
BR112014010164A2 (pt) | implante de tecido duro | |
CO6801724A2 (es) | Composiciones y métodos para el tratamiento de la mielofibrosis | |
BR112013018875A2 (pt) | métodos e composições para a preparação de noribogaína a partir de voacangina | |
EP2699256A4 (en) | COMPOSITIONS AND METHOD FOR TREATING NEUROMYELITIS OPTICA | |
BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
ITTO20110641A1 (it) | Composizioni farmaceutiche e metodi di trattamento | |
BR112012004080A2 (pt) | composições farmacêuticas para tratar ibd | |
EP2590674A4 (en) | COMPOSITIONS AND METHODS FOR INFLUENZA TREATMENT | |
SG2014014724A (en) | METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS | |
DK2734212T3 (da) | Sammensætninger omfattende diclofenac til behandling af postoperativ smerte | |
HK1200275A1 (en) | Disinfectant compositions and uses thereof | |
BRPI1013927A2 (pt) | métodos e composições para o tratamento de lúpus | |
BR112013003676A2 (pt) | composições de alimentos funcionais e métodos | |
BR112014004416A2 (pt) | composições e métodos para o tratamento de doenças neurodegenerativas | |
BR112013028890A2 (pt) | composições e métodos para o tratamento de câncer | |
BR112014013609A2 (pt) | composição antimicrobiana sólida, método da desinfecção de uma superfície e utilização de uma composição | |
BR112013018453A2 (pt) | métodos e composições para a prevenção e tratamento de osteoartrite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2494 DE 23-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |